Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

A Blauvelt; M Bruin-Weller; M Gooderham; JC Cather; J Weisman; D Pariser; EL Simpson; KA Papp; HCH Hong; D Rubel; P Foley; Errol Prens; CEM Griffiths; T Etoh; PH Pinto; RM Pujol; JC Szepietowski; K Ettler; L Kemeny; XP Zhu; B Akinlade; T Hultsch; V Mastey; A Gadkari; L Eckert; N Amin; NMH Graham; G Pirozzi; N Stahl; GD Yancopoulos; B Shumel

doi:10.1016/s0140-6736(17)31191-1

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

A Blauvelt
, M Bruin-Weller
, M Gooderham
, JC Cather
, J Weisman
, D Pariser
, EL Simpson
, KA Papp
, HCH Hong
, D Rubel
, P Foley
, Errol Prens
, CEM Griffiths
, T Etoh
, PH Pinto
, RM Pujol
, JC Szepietowski
, K Ettler
, L Kemeny
, XP Zhu

B Akinlade, T Hultsch, V Mastey, A Gadkari, L Eckert, N Amin, NMH Graham, G Pirozzi, N Stahl, GD Yancopoulos, B Shumel

Dermatology

Research output: Contribution to journal › Article › Academic › peer-review

1126 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2287-2303
Number of pages	17
Journal	Lancet (UK)
Volume	389
Issue number	10086
DOIs	https://doi.org/10.1016/s0140-6736(17)31191-1
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1016/s0140-6736(17)31191-1

http://hdl.handle.net/1765/99740

Cite this

Blauvelt, A., Bruin-Weller, M., Gooderham, M., Cather, JC., Weisman, J., Pariser, D., Simpson, EL., Papp, KA., Hong, HCH., Rubel, D., Foley, P., Prens, E., Griffiths, CEM., Etoh, T., Pinto, PH., Pujol, RM., Szepietowski, JC., Ettler, K., Kemeny, L., ... Shumel, B. (2017). Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet (UK), 389(10086), 2287-2303. https://doi.org/10.1016/s0140-6736(17)31191-1

@article{d1ad1d6eca1e4461b25b397ea8d72c77,

title = "Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial",

author = "A Blauvelt and M Bruin-Weller and M Gooderham and JC Cather and J Weisman and D Pariser and EL Simpson and KA Papp and HCH Hong and D Rubel and P Foley and Errol Prens and CEM Griffiths and T Etoh and PH Pinto and RM Pujol and JC Szepietowski and K Ettler and L Kemeny and XP Zhu and B Akinlade and T Hultsch and V Mastey and A Gadkari and L Eckert and N Amin and NMH Graham and G Pirozzi and N Stahl and GD Yancopoulos and B Shumel",

year = "2017",

doi = "10.1016/s0140-6736(17)31191-1",

language = "Undefined/Unknown",

volume = "389",

pages = "2287--2303",

journal = "Lancet (UK)",

issn = "0140-6736",

publisher = "Elsevier",

number = "10086",

}

Blauvelt, A, Bruin-Weller, M, Gooderham, M, Cather, JC, Weisman, J, Pariser, D, Simpson, EL, Papp, KA, Hong, HCH, Rubel, D, Foley, P, Prens, E, Griffiths, CEM, Etoh, T, Pinto, PH, Pujol, RM, Szepietowski, JC, Ettler, K, Kemeny, L, Zhu, XP, Akinlade, B, Hultsch, T, Mastey, V, Gadkari, A, Eckert, L, Amin, N, Graham, NMH, Pirozzi, G, Stahl, N, Yancopoulos, GD & Shumel, B 2017, 'Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial', Lancet (UK), vol. 389, no. 10086, pp. 2287-2303. https://doi.org/10.1016/s0140-6736(17)31191-1

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. / Blauvelt, A; Bruin-Weller, M; Gooderham, M et al.
In: Lancet (UK), Vol. 389, No. 10086, 2017, p. 2287-2303.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

AU - Blauvelt, A

AU - Bruin-Weller, M

AU - Gooderham, M

AU - Cather, JC

AU - Weisman, J

AU - Pariser, D

AU - Simpson, EL

AU - Papp, KA

AU - Hong, HCH

AU - Rubel, D

AU - Foley, P

AU - Prens, Errol

AU - Griffiths, CEM

AU - Etoh, T

AU - Pinto, PH

AU - Pujol, RM

AU - Szepietowski, JC

AU - Ettler, K

AU - Kemeny, L

AU - Zhu, XP

AU - Akinlade, B

AU - Hultsch, T

AU - Mastey, V

AU - Gadkari, A

AU - Eckert, L

AU - Amin, N

AU - Graham, NMH

AU - Pirozzi, G

AU - Stahl, N

AU - Yancopoulos, GD

AU - Shumel, B

PY - 2017

Y1 - 2017

U2 - 10.1016/s0140-6736(17)31191-1

DO - 10.1016/s0140-6736(17)31191-1

M3 - Article

SN - 0140-6736

VL - 389

SP - 2287

EP - 2303

JO - Lancet (UK)

JF - Lancet (UK)

IS - 10086

ER -